Head and neck squamous cell carcinoma and its correlation with human papillomavirus in people living with HIV: a systematic review

Over the last 20 years we assisted to an increase in the mean age of People Living with HIV and their comorbidities. Especially, there was an increase in Human Papillomavirus-related head and neck squamous cell carcinomas. Despite their increasing incidence in HIV-positive people, mechanisms that lead to their development and progression are only partially understood. The aim of this review is to identify key data and factors about HPV-related head and neck squamous cell carcinoma in HIV-seropositive patients. Systematic search and review of the relevant literature-peer-reviewed and grey-was conducted using the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines. We included in our review only the 35 full-text articles we considered the most substantial. It is mandatory to improve our knowledge about the interactions existing between HPV and HIV, and about their actions on oral mucosa immune system.

[1]  I. Frazer,et al.  Human papillomavirus infection among head and neck squamous cell carcinomas in southern China , 2019, PloS one.

[2]  A. Aydın,et al.  Investigation of human papillomavirus prevalence in married women and molecular characterization and phylogenetic analysis of the virus , 2019, Obstetrics & gynecology science.

[3]  A. Di Pietro,et al.  Knowledge of sexually transmitted infections and risky behaviours: a survey among high school and university students , 2019, Journal of preventive medicine and hygiene.

[4]  Xin-hua Liang,et al.  The Double-Edged Sword—How Human Papillomaviruses Interact With Immunity in Head and Neck Cancer , 2019, Front. Immunol..

[5]  G. Nunnari,et al.  Circulating angiopoietin-like protein 2 levels are associated with decreased renal function in HIV+ subjects on cART: A potential marker of kidney disease. , 2019, Biomedical reports.

[6]  G. Nunnari,et al.  Hepatitis C-related hepatocellular carcinoma: diagnostic and therapeutic management in HIV-patients. , 2018, European review for medical and pharmacological sciences.

[7]  M. Trovato,et al.  Serum interleukin-6 levels are increased in HIV-infected patients that develop autoimmune disease during long-term follow-up. , 2017, Immunobiology.

[8]  G. Nunnari,et al.  Kaposi's sarcoma in HIV-infected patients in the era of new antiretrovirals. , 2017, European review for medical and pharmacological sciences.

[9]  G. Madeddu,et al.  Editorial - Non AIDS-defining malignancies: a new epidemic in HIV-infected population for the upcoming decades? , 2017, European Review for Medical and Pharmacological Sciences.

[10]  J. Lee,et al.  High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV , 2016, Molecular Cancer Research.

[11]  U. Tirelli,et al.  New treatment strategies for HIV-positive cancer patients undergoing antiblastic chemotherapy , 2016, Expert opinion on pharmacotherapy.

[12]  Jiahong Xu,et al.  Prevalence and risk factors for oral DNA tumor viruses in HIV‐infected youth , 2016, Journal of medical virology.

[13]  Ross D. Cranston,et al.  The association of medication use with clearance or persistence of oral HPV infection , 2016, Cancer Causes & Control.

[14]  M. Currò,et al.  Prevalence of human papillomavirus in saliva of women with HPV genital lesions , 2016, Infectious Agents and Cancer.

[15]  R. Shaw,et al.  Aetiology and risk factors for head and neck cancer: United Kingdom National Multidisciplinary Guidelines , 2016, The Journal of Laryngology & Otology.

[16]  F. Younai.  Current Trends in the Incidence and Presentation of Oropharyngeal Cancer. , 2016, Journal of the California Dental Association.

[17]  P. Mondello,et al.  Kaposi ’ s sarcoma in HIV-infected patients : a review of the literature , 2016 .

[18]  A. Hristea,et al.  Kaposi Sarcoma in HIV Infected Patients , 2016 .

[19]  G. Nunnari,et al.  Diagnostic and therapeutic management of hepatocellular carcinoma. , 2015, World journal of gastroenterology.

[20]  U. Tirelli,et al.  Clinical presentation and outcome of non-AIDS defining cancers, in HIV-infected patients in the ART-era: the Italian Cooperative Group on AIDS and tumors activity. , 2015, European review for medical and pharmacological sciences.

[21]  G. Nunnari,et al.  Epstein-barr virus- and Kaposi sarcoma-associated herpesvirus-related malignancies in the setting of human immunodeficiency virus infection. , 2015, Seminars in oncology.

[22]  G. di Perri,et al.  Cerebrospinal fluid inhibitory quotients of antiretroviral drugs in HIV-infected patients are associated with compartmental viral control. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  Ross D. Cranston,et al.  Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults. , 2015, American journal of epidemiology.

[24]  G. Nunnari,et al.  HIV infection and bone disease: a review of the literature , 2015 .

[25]  G. Nasti,et al.  PRIMARY LIVER CANCER: CLINICAL ASPECTS, PROGNOSTIC FACTORS AND PREDICTIVE RESPONSE TO THERAPY , 2015 .

[26]  V. Canzonieri,et al.  HEPATOCELLULAR CARCINOMA : AN OVERVIEW OF CLINICO-PATHOLOGICAL AND MOLECULAR PERSPECTIVES , 2015 .

[27]  M. Santoro,et al.  HIV infection and kidney disease : literature review , 2015 .

[28]  Richard D Moore,et al.  Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals. , 2014, Oral oncology.

[29]  J. Lee,et al.  Epidemiology of Head and Neck Squamous Cell Cancer Among HIV-Infected Patients , 2014, Journal of acquired immune deficiency syndromes.

[30]  Liron Pantanowitz,et al.  Diagnosis and management of lymphomas and other cancers in HIV-infected patients , 2014, Nature Reviews Clinical Oncology.

[31]  R. Talamini,et al.  Lung cancer in HIV positive patients: the GICAT experience. , 2014, European review for medical and pharmacological sciences.

[32]  S. Zanetti,et al.  HPV infection in HIV-positive females: the need for cervical cancer screening including HPV-DNA detection despite successful HAART. , 2014, European review for medical and pharmacological sciences.

[33]  G. d’Ettorre,et al.  Kidney disease in HIV-infected patients. , 2013, European review for medical and pharmacological sciences.

[34]  G. Nunnari,et al.  Bone disease in the setting of HIV infection: update and review of the literature. , 2013, European review for medical and pharmacological sciences.

[35]  L. Patton,et al.  Urban legends series: oral manifestations of HIV infection. , 2013, Oral diseases.

[36]  P. Paoli,et al.  Kaposi' s sarcoma in HIV-positive patients: the state of art in the HAART-era. , 2013, European review for medical and pharmacological sciences.

[37]  E. Sugar,et al.  Natural history of anal vs oral HPV infection in HIV-infected men and women. , 2013, The Journal of infectious diseases.

[38]  A. García-Carrancá,et al.  HPV oral lesions in HIV-infected patients: the impact of long-term HAART. , 2013, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[39]  G. Nunnari,et al.  LPS and HIV gp120 modulate monocyte/macrophage CYP27B1 and CYP24A1 expression leading to vitamin D consumption and hypovitaminosis D in HIV-infected individuals. , 2013, European review for medical and pharmacological sciences.

[40]  G. Nunnari,et al.  Cryptococcal meningitis in an HIV-1-infected person: relapses or IRIS? Case report and review of the literature. , 2013, European review for medical and pharmacological sciences.

[41]  G. Nunnari,et al.  Sirtuin-1 and HIV-1: an overview. , 2013, Current drug targets.

[42]  S. D. De Rossi,et al.  Human papillomavirus: the fundamentals of HPV for oral health care providers. , 2013, Journal of the California Dental Association.

[43]  G. Guaraldi,et al.  Multicenter italian experience in liver transplantation for hepatocellular carcinoma in HIV-infected patients. , 2013, The oncologist.

[44]  G. Nunnari,et al.  High prevalence of undiagnosed anxiety symptoms among HIV-positive individuals on cART: a cross-sectional study. , 2013, European review for medical and pharmacological sciences.

[45]  A. Del Mistro,et al.  Oral Human Papillomavirus and Human Herpesvirus-8 Infections Among Human Immunodeficiency Virus Type 1–Infected Men and Women in Italy , 2012, Sexually transmitted diseases.

[46]  G. Nunnari,et al.  Immuno-modulatory effects of vitamin D3 in human monocyte and macrophages. , 2012, Cellular immunology.

[47]  R. Talamini,et al.  Pancreatic Cancer in HIV-Positive Patients: A Clinical Case-Control Study , 2012, Pancreas.

[48]  G. Nunnari,et al.  Non-AIDS-defining cancers among HIV-infected people. , 2012, European review for medical and pharmacological sciences.

[49]  V. Cavallari,et al.  Bioenergetics of T cell activation and death in HIV type 1 infection. , 2012, AIDS research and human retroviruses.

[50]  G. Nunnari,et al.  The role of micronutrients in the diet of HIV-1-infected individuals. , 2012, Frontiers in bioscience.

[51]  G. Nunnari,et al.  HIV RNA Suppression and Immune Restoration: Can We Do Better? , 2012, Clinical & developmental immunology.

[52]  Ross D. Cranston,et al.  Risk Factors for Oral HPV Infection among a High Prevalence Population of HIV-Positive and At-Risk HIV-Negative Adults , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[53]  S. Tugizov,et al.  Mechanisms of Viral Infections Associated with HIV , 2011, Advances in dental research.

[54]  S. Syrjänen,et al.  Human Papillomavirus Infection and Its Association with HIV , 2011, Advances in dental research.

[55]  U. Tirelli,et al.  Anal cancer: Focus on HIV-positive patients in the HAART-era. , 2011, Current HIV research.

[56]  M. Vivarelli,et al.  HIV-infected patients and liver transplantation: who, when and why. , 2011, Current HIV research.

[57]  G. Castro,et al.  Human papillomavirus in the oral cavity of children. , 2011, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[58]  G. Guaraldi,et al.  Hepatocellular carcinoma in HIV-infected patients: check early, treat hard. , 2011, The oncologist.

[59]  Hui Zhang,et al.  Exogenous IL-7 induces Fas-mediated human neuronal apoptosis: potential effects during human immunodeficiency virus type 1 infection , 2005, Journal of NeuroVirology.

[60]  M. Paiardini,et al.  Intracellular accumulation of cell cycle regulatory proteins and nucleolin re-localization are associated with pre-lethal ultrastructural lesions in circulating T lymphocytes: The HIV-induced cell cycle dysregulation revisited , 2010, Cell cycle.

[61]  S. de Sanjosé,et al.  Laryngeal squamous cell carcinoma in HIV‐positive patients: lack of association with human papillomavirus infection , 2009, HIV medicine.

[62]  R. Biggar,et al.  Risk of human papillomavirus-associated cancers among persons with AIDS. , 2009, Journal of the National Cancer Institute.

[63]  R. Talamini,et al.  Plasma HHV‐8 viral load in HHV‐8‐related lymphoproliferative disorders associated with HIV infection , 2009, Journal of medical virology.

[64]  V. Canzonieri,et al.  Leiomyosarcoma of the Parotid Gland in an HIV-Positive Patient: Therapeutic Approach, Clinical Course and Review of the Literature , 2009, Journal of chemotherapy.

[65]  A. Kreuter,et al.  Human papillomavirus-associated diseases in HIV-infected men who have sex with men , 2009, Current opinion in infectious diseases.

[66]  P. Infante-Cossio,et al.  Oral inverted ductal papilloma associated with condyloma acuminata and HPV in an HIV+ patient. , 2008, International journal of oral and maxillofacial surgery.

[67]  E. Nkenke,et al.  HPV detection rate in saliva may depend on the immune system efficiency. , 2008, In vivo.

[68]  G. Guaraldi,et al.  Human immunodeficiency virus and liver transplantation: our point of view. , 2008, Transplantation proceedings.

[69]  U. Tirelli,et al.  Unusual Presentation of Metastatic Hepatocellular Carcinoma in an HIV/HCV Coinfected Patient: Case Report and Review of the Literature , 2008, Tumori.

[70]  Edu,et al.  Journal of Experimental & Clinical Cancer Research Hiv-1 Tat and Aids-associated Cancer: Targeting the Cellular Anti-cancer Barrier? Aids and Cancer Two Other Types of Cancer Have Been Associated with Aids. Hiv-1 Infected Patients Develop Lymphomas at Relatively , 2008 .

[71]  M. Masetti,et al.  Hepatocellular carcinoma in HIV patients treated by liver transplantation. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[72]  M. Luppi,et al.  Kaposi’s sarcoma after liver transplantation , 2008, Journal of Cancer Research and Clinical Oncology.

[73]  P. Altmeyer,et al.  Rapid onset of multifocal human papillomavirus 72‐associated oral intraepithelial neoplasia in a human immunodeficiency virus‐infected patient , 2007, The British journal of dermatology.

[74]  R. Daniel,et al.  Pentoxifylline Suppresses Transduction by HIV-1-Based Vectors , 2007, Intervirology.

[75]  U. Tirelli,et al.  Cetuximab/Targeted Chemotherapy in an HIV-Positive Patient with Metastatic Colorectal Cancer in the HAART Era: a Case Report , 2007, Journal of chemotherapy.

[76]  M. Masetti,et al.  Don't deny liver transplantation to HIV patients with hepatocellular carcinoma in the highly active antiretroviral therapy era. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[77]  M. Hagensee,et al.  The Impact of Highly Active Antiretroviral Therapy and Immunodeficiency on Human Papillomavirus Infection of the Oral Cavity of Human Immunodeficiency Virus–Seropositive Adults , 2005, Sexually transmitted diseases.

[78]  R. Pomerantz,et al.  IL-7 as a potential therapy for HIV-1-infected individuals , 2005, Expert opinion on biological therapy.

[79]  R. Pomerantz,et al.  Seminal reservoirs during an HIV type 1 eradication trial. , 2005, AIDS research and human retroviruses.

[80]  P. Nyirjesy,et al.  HIV type 1 cervicovaginal reservoirs in the era of HAART. , 2005, AIDS research and human retroviruses.

[81]  M. Hagensee,et al.  Lack of evidence for local immune activity in oral hairy leukoplakia and oral wart lesions. , 2005, Oral Microbiology and Immunology.

[82]  M. Thomson,et al.  IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART. , 2005, The Journal of clinical investigation.

[83]  A. Alberg,et al.  Gender Differences in Sexual Biomarkers and Behaviors Associated With Human Papillomavirus-16, −18, and −33 Seroprevalence , 2004, Sexually transmitted diseases.

[84]  M. Berretta,et al.  CD90/Thy‐1 is preferentially expressed on blast cells of high risk acute myeloid leukaemias * , 2004, British journal of haematology.

[85]  R. Pomerantz,et al.  HIV and GB virus C--can two viruses be better than one? , 2004, The New England journal of medicine.

[86]  A. d’Arminio Monforte,et al.  Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome–related Kaposi sarcoma , 2003, Cancer.

[87]  U. Tirelli,et al.  Therapeutic approaches to AIDS-related malignancies , 2003, Oncogene.

[88]  U. Tirelli,et al.  Hodgkin's disease in HIV. , 2003, Hematology/oncology clinics of North America.

[89]  D. Reznik,et al.  Oral manifestations in the era of HAART. , 2003, Journal of the National Medical Association.

[90]  G. Nuovo,et al.  Human papillomavirus, type 40-associated papilloma, and concurrent Kaposi's sarcoma involving the anterior hard palate of an HIV-positive man. , 2003, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[91]  R. Jordan,et al.  Proliferation and invasion factors in HIV-associated dysplastic and nondysplastic oral warts and in oral squamous cell carcinoma: an immunohistochemical and RT-PCR evaluation. , 2002, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[92]  N. Raab-Traub,et al.  Mechanisms of expression of HHV8, EBV and HPV in selected HIV-associated oral lesions. , 2002, Oral diseases.

[93]  M. A. Gómez,et al.  HPV in "carcinoma in situ" associated with HIV/AIDS infection: a case report. , 2002, Medicina oral : organo oficial de la Sociedad Espanola de Medicina Oral y de la Academia Iberoamericana de Patologia y Medicina Bucal.

[94]  Hui Zhang,et al.  Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections , 2002, AIDS.

[95]  Hui Zhang,et al.  Human immunodeficiency virus type 1-infected persons with residual disease and virus reservoirs on suppressive highly active antiretroviral therapy can be stratified into relevant virologic and immunologic subgroups. , 2001, The Journal of infectious diseases.

[96]  P. Reichart.  Clinical management of selected oral fungal and viral infections during HIV-disease. , 1999, International dental journal.